Access to antiretroviral treatment has greatly increased in the last decades, but the number of HIV-related deaths has plateaued, and 1 million lives are lost to preventable infections every year. People continue to develop late-stage HIV because of  treatment interruption and more and more often, treatment failure.

Unitaid’s new investment is designed to widen access to WHO-recommended drugs and tests for advanced HIV disease, transforming its diagnosis and treatment. Interventions will also lay the foundations for governments and partners to bring that package to everyone in need in low- and lower-middle-income countries.

Check out the stories below to hear from leading voices in the field on why cutting deaths from advanced HIV can be a vital tactic in ending the epidemic.

Unitaid’s work in advanced HIV disease:

• Unitaid invests to cut HIV-related deaths
• A plan to slash HIV deaths
• Unitaid and CHAI sign grant to prevent cervical cancer deaths
• Five facts about cervical cancer and how Unitaid is battling the disease
• Unitaid launches initiative to avert deaths from advanced HIV
• Nine quick facts about Unitaid’s investment in advanced HIV
• Stopping preventable deaths among people with advanced HIV disease (Project page)
• Unitaid and HIV/AIDS (Factsheet)
• Unitaid HIV Portfolio (Factsheet)
• Cervical cancer. Screening and treatment of pre-cancerous lesions for secondary prevention of cervical cancer (Technology landscape)
• Unitaid launches call for proposals to help eliminate cervical cancer